Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.


It is well recognised that haemodialysis and renal transplant patients are at increased risk of developing non-A, non-B hepatitis. Recently the genome of hepatitis C virus (HCV), the major causative agent for non-A, non-B hepatitis, has been isolated. Anti-HCV seroprevalence was assessed in all haemodialysis patients (266) in Ireland who in March 1990 had… (More)


  • Presentations referencing similar topics